Clinical Trials Directory

Trials / Conditions / Chagas Disease

Chagas Disease

57 registered clinical trials studyying Chagas Disease4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAn Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to L
NCT05477953
Bayer
RecruitingA Study of Efficacy, Safety, Tolerability of LXE408 in Participants With Chronic Chagas Disease.
NCT06632600
Novartis PharmaceuticalsPhase 2
Enrolling By InvitationUniversity-Based Chagas Testing in Salta Province, Argentina
NCT07033325
Mundo Sano Foundation
CompletedDelivering a Multi-disease Screening Tool to Migrant Populations
NCT05868005
Barcelona Institute for Global HealthN/A
RecruitingShorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease
NCT04897516
Laboratorio Elea Phoenix S.A.Phase 3
Active Not RecruitingSBRT in Chagas Disease Ventricular Tachycardia
NCT04984265
University of Sao Paulo General HospitalPhase 1 / Phase 2
CompletedNew Therapies and Biomarkers for Chagas Infection
NCT03981523
University of Texas, El PasoPhase 2
CompletedEfficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Cha
NCT04023227
Novartis PharmaceuticalsPhase 4
Active Not RecruitingProspective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease
NCT04024163
Insud PharmaPhase 3
UnknownImplementation Strategy of Bio-molecular Techniques for Early Diagnose of Congenital Syphilis and Chagas Disea
NCT04084379
Hospital de Niños R. Gutierrez de Buenos Aires
CompletedStudy to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients - Di
NCT03334838
BayerPhase 1
CompletedShort-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
NCT03672487
Tulane University School of Public Health and Tropical MedicinePhase 3
CompletedStudy on Benefits of Therapy With Nifurtimox in Chagas Disease, a Parasitic Illness Mostly Transmitted to Huma
NCT03784391
Bayer
UnknownColchicine for Patients With Chagas´ Disease( B1 Stage)
NCT03704181
University of Sao Paulo General HospitalPhase 2
CompletedStudy Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg
NCT03350295
BayerPhase 1
UnknownNifurtimox Versus Benznidazole Effectiveness and Tolerance for Chagas Disease Treatment
NCT04274101
Hospital de Niños R. Gutierrez de Buenos Aires
CompletedEvaluation of Different Benznidazole Regimens for the Treatment of Chronic Chagas Disease.
NCT03191162
Hospital Universitari Vall d'Hebron Research InstitutePhase 2
UnknownBENDITA BEnznidazole New Doses Improved Treatment and Associations
NCT03378661
Drugs for Neglected DiseasesPhase 2
CompletedA Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Dise
NCT02625974
BayerPhase 3
CompletedStudy to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients
NCT02606864
BayerPhase 1
UnknownCHICAMOCHA 3 - Equivalence of Usual Interventions for Trypanosomiasis (EQUITY)
NCT02369978
Universidad Autónoma de BucaramangaPhase 2 / Phase 3
CompletedDetermination of Genetic Polymorphisms in Chronic Chagas Cardiomyopathy
NCT02346123
Hospital Sao Rafael
CompletedPhysical Exercise Program in Chronic Chagas Heart Disease
NCT02517632
Evandro Chagas National Institute of Infectious DiseasePhase 3
CompletedCongenital Chagas Disease: Long Term Follow up of Treated Children. Preliminary Report or Cardiological Evalua
NCT04090489
Hospital de Niños R. Gutierrez de Buenos Aires
CompletedPharmacokinetic Drug-Drug Interaction Study
NCT03892213
Drugs for Neglected DiseasesPhase 1
UnknownStudy to Evaluate Fexinidazole Dosing Regimens for the Treatment of Adult Patients With Chagas Disease
NCT02498782
Drugs for Neglected DiseasesPhase 2
UnknownRenal Denervation in Patients With Heart Failure Secondary to Chagas Disease
NCT02099903
InCor Heart InstituteN/A
CompletedStudy to Assess Bioequivalence of 30 and 120 mg Nifurtimox Tablets in Chronic Chagas' Patients
NCT01927224
BayerPhase 1
CompletedLongitudinal Study of Patients With Chronic Chagas Cardiomyopathy in Brazil (SaMi_Trop Project)
NCT02646943
University of Sao Paulo
TerminatedReveal Chagas: Clinical Evidence of the Implantable Cardiac Monitor in Patients With Chagas Disease
NCT01539161
Medtronic Cardiac Rhythm and Heart FailurePhase 4
UnknownExercise Training in Patients With Chagasic Heart Disease Without Ventricular Dysfunction
NCT02295215
University of Sao Paulo General HospitalN/A
CompletedCardiac Rehabilitation in Chagas Heart Failure
NCT02516293
Evandro Chagas National Institute of Infectious DiseasePhase 2 / Phase 3
CompletedNew Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease
NCT01755377
Barcelona Centre for International Health Research
CompletedStudy Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
NCT01744405
Hospital de Niños R. Gutierrez de Buenos Aires
CompletedPopulation Pharmacokinetics in Benznidazole-treated Adults With Chronic With Chagas Disease
NCT01755403
Barcelona Centre for International Health ResearchPhase 4
CompletedImproving Blood Safety and HIV Testing in Brazil
NCT01681420
Vitalant Research InstituteN/A
CompletedAbbott ESA Chagas Assay Post-Market Study
NCT01662362
Abbott Diagnostics DivisionN/A
CompletedEffect of Ganglionar Electrical Stimulation on Central Arterial Pressure
NCT01874795
University of BrasiliaN/A
CompletedStudy of Benznidazole Transfer Into Breastmilk in Lactating Women With Chagas Disease
NCT01547533
Hospital de Niños R. Gutierrez de Buenos Aires
CompletedA Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)
NCT01377480
Merck Sharp & Dohme LLCPhase 2
CompletedPopulation Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease
NCT01549236
Drugs for Neglected DiseasesPhase 4
CompletedCongenital Transmission of Lineages I and II of Trypanosoma Cruzi
NCT01787968
Tulane University School of Public Health and Tropical Medicine
CompletedOptimization of PCR Technique to Assess Parasitological Response for Patients With Chronic Chagas Disease
NCT01678599
Drugs for Neglected DiseasesPhase 4
CompletedGalectin-3 as a Biomarker in Patients With Chagas Disease
NCT01842854
Hospital Sao Rafael
CompletedSyndecan-4 as a Biomarker in Patients With Chagas Disease
NCT01842867
Hospital Sao Rafael
CompletedAssessment of Speckle Tracking Strain Predictive Value for Myocardial Fibrosis in Chagas Disease
NCT02327052
Hospital Sao Rafael
CompletedMicroRNAs as Biomarkers in Patients With Chagas Disease
NCT01842880
Hospital Sao Rafael
CompletedClinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
NCT01162967
Hospital Universitari Vall d'Hebron Research InstitutePhase 2
CompletedOutcomes of an Anticoagulation Clinic in an University Hospital
NCT01006486
Federal University of Minas GeraisPhase 4
UnknownSelenium Treatment and Chagasic Cardiopathy (STCC)
NCT00875173
Oswaldo Cruz FoundationPhase 3
CompletedPopulation Pharmacokinetics of Benznidazole in Children With Chagas Disease
NCT00699387
Hospital de Niños R. Gutierrez de Buenos AiresN/A
CompletedExercise Training in Chagas Cardiomyopathy
NCT01006473
Federal University of Minas GeraisPhase 4
CompletedPrevalence of Chagas Disease in Immigrant Patients With Conduction Abnormalities on Electrocardiogram
NCT00453700
Olive View-UCLA Education & Research Institute
CompletedBENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Diseas
NCT00123916
Population Health Research InstitutePhase 3
CompletedGenetic Architecture of Heart Disease in Rural Brazil
NCT00023556
National Heart, Lung, and Blood Institute (NHLBI)
CompletedEtiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Tri
NCT02386358
Instituto Nacional de Parasitologia Dr. Mario Fatala ChabenPhase 3
CompletedChagas Disease as an Undiagnosed Type of Cardiomyopathy in the United States
NCT00005455
National Heart, Lung, and Blood Institute (NHLBI)